## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -0.8% below STRENGTH zone (4.0-10.0%); PEG 1.84 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($71.28)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Marshall Wace LLP Buys 1,948,827 Shares of Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251206T115408 | Bullish | Relevance: 99%
-  Marshall Wace LLP significantly increased its stake in Monster Beverage Corporation by 1,126.9% in Q2, acquiring 1,948,827 new shares to hold a total of 2,121,758 shares valued at $132.9 million. This makes them a substantial institutional investor, holding approximately 0.22% of the company. Monster Beverage recently surpassed earnings expectations with an EPS of $0.56 and revenue of $2.20 billion, indicating strong financial performance.

**2. California Public Employees Retirement System Acquires 112,614 Shares of Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251209T102327 | Bullish | Relevance: 97%
- California Public Employees Retirement System increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 9.3% in the second quarter, acquiring an additional 112,614 shares. The firm now owns 1,324,626 shares worth $82,975,000, representing 0.14% of the company's stock. Other institutional investors also adjusted their holdings in MNST, with several analysts maintaining "buy" ratings and an average target price of $71.45.

**3. Amundi Sells 569,337 Shares of Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251207T081847 | Somewhat-Bullish | Relevance: 97%
-  Amundi reduced its stake in Monster Beverage Corporation (NASDAQ:MNST) by 18.8% in the second quarter, selling 569,337 shares and leaving its holding at 2,463,254 shares valued at $155,284,000. Other institutional investors also adjusted their positions in MNST, while insider Guy Carling sold 38,438 shares, decreasing his ownership by over 63%. Analysts maintain a "Moderate Buy" consensus rating for Monster Beverage, with several firms raising their price targets.

**4. The Zacks Analyst Blog Highlights Monster Beverage, MongoDB and Lumentum**
- Source: The Globe and Mail | 20251209T140827 | Bullish | Relevance: 97%
-  This Zacks Analyst Blog highlights Monster Beverage (MNST), MongoDB (MDB), and Lumentum (LITE), detailing their company profiles and market positions. It also provides a global economic outlook, discussing upcoming central bank meetings, particularly the U.S. Federal Reserve, and anticipates China's macro data while observing a potentially over-optimistic market sentiment for 2026. The article identifies these three stocks as "Zacks #1 Rank (STRONG BUY)" picks, offering detailed insights into their business segments, market capitalization, and Zacks scores for value, growth, and momentum.

**5. Ossiam Reduces Stock Holdings in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251208T115534 | Somewhat-Bullish | Relevance: 96%
-  Ossiam, an institutional investor, decreased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 7.5% in Q2 2025, selling 53,438 shares. Following this, Ossiam now holds 658,270 shares valued at approximately $41.23 million. Additionally, insider Guy Carling sold 38,438 shares of company stock in November, reducing his position by over 63%.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |
| 2025-12-03 | Wells Fargo | $83 | $75 | +11% |
| 2025-12-03 | BMO Capital | $73 | $53 | +38% |
| 2025-12-01 | RBC Capital | $81 | $75 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Piper Sandler | main | Overweight |
| 2025-12-03 | Wells Fargo | main | Overweight |
| 2025-12-03 | BMO Capital | main | Market Perform |
| 2025-12-01 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.74M) |
| Sells | 5 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-3.0% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +15%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.84 elevated, pricing in significant growth expectations. Forward P/E 33.3x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (6 raises, avg +15%). Insider buying signal ($0.7M), management confidence. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.2B |
| Beta | 0.48 |
| 52W Range | $45.70 - $76.28 |
| Short Interest | 2.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.84 |
| Forward P/E | 33.3 |
| Current P/E | 37.6 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.3% to -0.8% (-3.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.76% (CS: 51) | Neutral |
| RSI_14 | 59.4 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.054x | Above |
| vs SMA200 | 1.173x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $73.94
- **Stop Loss:** $71.28 (3.6% risk)
- **Target:** $76.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 187
- **Position Value:** $13,826.78
- **Portfolio %:** 13.83%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*